In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
All content for Genetic Sounds is the property of The European Society of Human Genetics and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
In this episode, we discuss “What exactly is a centre for rare conditions?” A conversation with Professor Siddharth Banka from the University of Manchester, Professor Gareth Baynam from Australian National University’s National Centre for Indigenous Genomics, and Dame Laura Lee, the first employee and now CEO of Maggie’s, a charity providing free cancer support and information in centres across the UK and online.
Genetic Sounds
In the final episode of our third series, we discuss Pharmacogenetics. Recorded with a live audience in Berlin, Germany. On the panel we have a wonderful range of guests including Professor and Head of Estonian Biobank, Lili Milani, CEO of Unique Patient Group, Sara Winn, Vita Dolžan, Head of the Pharmacogenetics Laboratory at the Faculty of Medicine at the University of Ljubljana, and Bill Newman, Clinical Geneticist and Vice President of the ESHG.
